Gamma-Aminobutyric Acid, Glutamate, and Cognition in Early Stages of Psychosis: Are We Closing the Gap?

Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jun;5(6):558-559. doi: 10.1016/j.bpsc.2020.04.006.

Authors

Lawrence S Kegeles¹, Camilo de la Fuente-Sandoval²

Affiliations

¹ Departments of Psychiatry and Radiology, Columbia University, New York, New York; New York State Psychiatric Institute, New York, New York.
² Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Neuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. Electronic address: fcamilo@unam.mx.

PMID: 32513389
DOI: 10.1016/j.bpsc.2020.04.006

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cognition
Glutamic Acid*
Humans
Psychotic Disorders*
gamma-Aminobutyric Acid

Substances

Glutamic Acid
gamma-Aminobutyric Acid

Grants and funding